The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2

por Enogieru, Osatohanmwen J., Koleske, Megan L., Vora, Bianca, Ngo, Huy, Yee, Sook Wah, Chatad, Derrick, Sirota, Marina, Giacomini, Kathleen M.
Publicado 2021

Predicting changes in the pharmacokinetics of CYP3A‐metabolized drugs in hepatic impairment and insights into factors driving these changes

por Ladumor, Mayur K., Storelli, Flavia, Liang, Xiaomin, Lai, Yurong, Enogieru, Osatohanmwen J., Chothe, Paresh P., Evers, Raymond, Unadkat, Jashvant D.
Publicado 2022

Drugs in COVID‐19 Clinical Trials: Predicting Transporter‐Mediated Drug‐Drug Interactions Using In Vitro Assays and Real‐World Data

por Yee, Sook Wah, Vora, Bianca, Oskotsky, Tomiko, Zou, Ling, Jakobsen, Sebastian, Enogieru, Osatohanmwen J., Koleske, Megan L., Kosti, Idit, Rödin, Mattias, Sirota, Marina, Giacomini, Kathleen M.
Publicado 2021